Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Convalescent plasma Emergency use authorization Experimental Antiviral Jan/15/2021 27 5
Emetine Potential treatment - pre-clinical evidence Experimental Antiviral Jan/15/2021 6 0
Maduramicin Potential treatment - pre-clinical evidence Experimental Antiviral Jan/15/2021 2 0
Bisindolylmaleimide IX Potential treatment - pre-clinical evidence Experimental Antiviral Jan/14/2021 1 0
NVX-CoV2373 Potential treatment - clinical evidence Experimental Vaccine Jan/14/2021 4 0
Peptide #2 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/11/2021 1 0
CR-31-B (-) Potential treatment - pre-clinical evidence Experimental Antiviral Jan/08/2021 1 0
Sar9, Met (O2)11-Substance P Potential treatment - theoretical effect Experimental Antiviral Jan/08/2021 1 0
Adjuvanted SARS-CoV-2 Spike protein Potential treatment - pre-clinical evidence Experimental Vaccine Jan/07/2021 1 0
Remikiren Potential treatment - theoretical effect Experimental Antiviral Dec/24/2020 1 0